Skip to content

Matinas BioPharma Holdings Inc Sustainability Reports

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies using its lipid nanocrystal platform delivery technology.

Sector: Manufacturing

Country: United States

Exchange: NYSE American

ISIN: US5768101058

1 reports from 2020 to 2020